ProfileGDS4284 / 204818_at
TitleChronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood
OrganismHomo sapiens


control 0.2 mg/kg 1 mg/kg 2 mg/kg 4 mg/kg 6 mg/kg pre-treatment 24 hrs 4 wks 24 hrs 4 wks 24 hrs 4 wks 4 hrs 24 hrs 4 wks 4 hrs 24 hrs 4 wks 401 402 403 404 411 422 424 425 427 428 441 443 444 448 449 450 451 452 401 402 411 402 411 422 403 424 427 403 424 427 428 449 450 425 428 443 444 449 450 425 428 443 449 450 404 448 451 452 404 441 448 451 452 451 452 GSM687644 GSM687648 GSM687653 GSM687658 GSM687663 GSM687668 GSM687673 GSM687678 GSM687683 GSM687688 GSM687695 GSM687699 GSM687704 GSM687707 GSM687712 GSM687719 GSM687724 GSM687728 GSM687646 GSM687649 GSM687665 GSM687651 GSM687667 GSM687670 GSM687671 GSM687654 GSM687675 GSM687685 GSM687656 GSM687677 GSM687687 GSM687692 GSM687716 GSM687722 GSM687680 GSM687690 GSM687700 GSM687705 GSM687714 GSM687721 GSM687682 GSM687694 GSM687702 GSM687718 GSM687723 GSM687661 GSM687710 GSM687726 GSM687730 GSM687660 GSM687697 GSM687709 GSM687725 GSM687729 GSM687727 GSM687731 8% 2% 1% 5% 8% 1% 9% 1% 7% 11% 9% 22% 1% 1% 28% 4% 1% 4% 16% 7% 2% 2% 1% 4% 6% 4% 5% 1% 12% 2% 1% 16% 1% 8% 10% 3% 8% 25% 1% 1% 1% 9% 1% 2% 10% 1% 9% 2% 12% 2% 19% 5% 8% 1% 2% 8% sort by dose sort by time sort by individual Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM687644Patient 401 control12.58688
GSM687648Patient 402 control5.431972
GSM687653Patient 403 control4.201711
GSM687658Patient 404 control10.5935
GSM687663Patient 411 control15.41278
GSM687668Patient 422 control4.335191
GSM687673Patient 424 control16.59019
GSM687678Patient 425 control5.016891
GSM687683Patient 427 control14.5947
GSM687688Patient 428 control16.779911
GSM687695Patient 441 control29.73889
GSM687699Patient 443 control57.264222
GSM687704Patient 444 control3.729091
GSM687707Patient 448 control6.661261
GSM687712Patient 449 control70.286428
GSM687719Patient 450 control11.00774
GSM687724Patient 451 control6.459621
GSM687728Patient 452 control9.764144
GSM687646Patient 401 treated 24h27.093316
GSM687649Patient 402 treated 24h10.30547
GSM687665Patient 411 treated 24h6.652462
GSM687651Patient 402 treated 4 weeks5.940842
GSM687667Patient 411 treated 4 weeks4.344411
GSM687670Patient 422 treated 24h9.007924
GSM687671Patient 422 treated 4 weeks10.89736
GSM687654Patient 403 treated 24h7.308694
GSM687675Patient 424 treated 24h12.31255
GSM687685Patient 427 treated 24h2.799271
GSM687656Patient 403 treated 4 weeks17.892812
GSM687677Patient 424 treated 4 weeks5.303032
GSM687687Patient 427 treated 4 weeks2.932831
GSM687692Patient 428 treated 4h28.149116
GSM687716Patient 449 treated 4h5.006861
GSM687722Patient 450 treated 4h18.04588
GSM687680Patient 425 treated 24h17.437910
GSM687690Patient 428 treated 24h6.315123
GSM687700Patient 443 treated 24h25.0728
GSM687705Patient 444 treated 24h52.523425
GSM687714Patient 449 treated 24h2.318771
GSM687721Patient 450 treated 24h5.909331
GSM687682Patient 425 treated 4 weeks3.676951
GSM687694Patient 428 treated 4 weeks12.85029
GSM687702Patient 443 treated 4 weeks3.8021
GSM687718Patient 449 treated 4 weeks6.259462
GSM687723Patient 450 treated 4 weeks18.912410
GSM687661Patient 404 treated 4h5.325211
GSM687710Patient 448 treated 4h15.92849
GSM687726Patient 451 treated 4h6.457342
GSM687730Patient 452 treated 4h52.157512
GSM687660Patient 404 treated 24h9.565932
GSM687697Patient 441 treated 24h52.023519
GSM687709Patient 448 treated 24h11.92485
GSM687725Patient 451 treated 24h18.62528
GSM687729Patient 452 treated 24h5.750271
GSM687727Patient 451 treated 4 weeks8.186192
GSM687731Patient 452 treated 4 weeks15.74648